Biliary tract cancers: moving from the present standards of care towards the use of immune checkpoint inhibitors.

Pezzicoli, Gaetano; Triggiano, Giacomo; Sergi, Maria Chiara; Mannavola, Francesco; Porta, Camillo; Tucci, Marco

Pezzicoli, Gaetano; Triggiano, Giacomo; Sergi, Maria Chiara; Mannavola, Francesco; Porta, Camillo; Tucci, Marco.

Afiliação

Pezzicoli G; Department of Biomedical Sciences and Human Oncology, University of Bari 'Aldo Moro' and Division of Medical Oncology, A.O.U. Consorziale Policlinico di Bari Bari, Italy.
Triggiano G; Department of Biomedical Sciences and Human Oncology, University of Bari 'Aldo Moro' and Division of Medical Oncology, A.O.U. Consorziale Policlinico di Bari Bari, Italy.
Sergi MC; Department of Biomedical Sciences and Human Oncology, University of Bari 'Aldo Moro' and Division of Medical Oncology, A.O.U. Consorziale Policlinico di Bari Bari, Italy.
Mannavola F; Department of Biomedical Sciences and Human Oncology, University of Bari 'Aldo Moro' and Division of Medical Oncology, A.O.U. Consorziale Policlinico di Bari Bari, Italy.
Porta C; Department of Biomedical Sciences and Human Oncology, University of Bari 'Aldo Moro' and Division of Medical Oncology, A.O.U. Consorziale Policlinico di Bari Bari, Italy.
Tucci M; Department of Biomedical Sciences and Human Oncology, University of Bari 'Aldo Moro' and Division of Medical Oncology, A.O.U. Consorziale Policlinico di Bari Bari, Italy.

Am J Transl Res ; 13(8): 8598-8610, 2021.

Article em En | MEDLINE | ID: mdl-34539982

Palavras-chave

Biliary tract cancers; biomarkers; chemotherapy; combinations; immune checkpoint inhibitors

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Am J Transl Res Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Itália

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google